Oxford Investment Consultants backs founders turning scientific research into products addressing global challenges.
Portfolio
6
companies
Brill Power
Brill Power develops intelligent battery management systems to improve energy storage and vehicle performance.
Caristo Diagnostics
Caristo Diagnostics develops AI-assisted tools for cardiac and vascular disease diagnostics.
Navenio
Navenio provides indoor location technology and task allocation software to improve healthcare workflow efficiency.
Oxford Endovascular
Oxford Endovascular develops origami-inspired medical devices for brain aneurysm treatment.
Oxford Quantum Circuits
Oxford Quantum Circuits develops advanced quantum computing hardware using patented 3D architecture.
Salience Labs
Salience Labs builds ultra high-speed multi-chip processors that combine photonics and electronics for artificial intelligence applications.
The financing round was led by Oxford Science Enterprises and will support market expansion in the UK, EU, and United States.
"We are thrilled that five successful institutional investors participated in the financing round which validates the vast clinical and business potential of Caristo’s innovations"
The funding will support team growth and product development for energy storage and electric vehicles.
"As we grow our climate and clean energy platform, investing in Brill Power is an exciting move into energy storage technologies that are crucial to enable an increase of renewables on the power grid, electrification of transport, and to power our homes, businesses and key infrastructure. Through extended lifetimes, improved safety, and waste reduction, Brill Power’s work is setting a new standard for how to store and use clean power to accelerate progress to our net zero emissions goals."
The financing was co-led by Lansdowne Partners and The University of Tokyo Edge Capital Partners.
"Quantum computing promises to be the next frontier of innovation, and OQC, with its state-of-the-art Coaxmon technology, aims to integrate the forefront of modern physics into our everyday lives. UTEC is honoured to be part of OQC’s mission of making quantum technology accessible to all and will support OQC’s expansion into Asia-Pacific through collaborations with academia including the University of Tokyo, and partnerships with Japan’s leading financial and tech corporations."
The seed round was co-led by Cambridge Innovation Capital and Oxford Science Enterprises to accelerate the development of photonic artificial intelligence processors.
"Salience Labs brings together deep domain expertise in photonics, electronics and CMOS manufacture."
The Oxford Science Enterprises-led round will support US expansion and continued domestic growth in healthcare.
"I’m delighted our investors have again demonstrated their belief in the vast potential that Navenio can bring by ensuring ‘right person, right place, right time’. Artificial intelligence is one of many technologies making a real-world impact in the health sector, and this investment enables the company to rapidly spearhead international digital transformation."
